Synapse

  • About
  • FAQ
  • Reports
  • Contact Us
  • Memorial Sloan Kettering Cancer Center

  • Works
  • Groups
  • People
  • Publications
  • Publishers
  • In Press
Advanced
Search Within

Fernando Costa Santini

  • Home
  • Works
  • Groups
  • Dashboard
  1. "Early Drug Development Service"
Formats
  1. Journal Article (1)
Groups
  1. Department of Medicine (1)
  2. Early Drug Development Service (1)
  3. Gynecologic Medicine Service (1)
  4. Solid Tumor Oncology Division (1)
  5. Thoracic Oncology (1)
  6. Weinberg Fellows (1)
People
  1. Alexander Drilon (1)
  2. Alison Schram (1)
  3. Chebli Mrad (1)
  4. Isabella Bergagnini (1)
  5. Joshua Sabari (1)
  6. Kathryn Arbour (1)
  1. Alexander Drilon (1)
  2. Alison Schram (1)
  3. Chebli Mrad (1)
  4. Isabella Bergagnini (1)
  5. Joshua Sabari (1)
  6. Kathryn Arbour (1)
  7. Ruqin Chen (1)
  8. Wei-Chu Lai (1)

More People

Fewer People

Years
  1. 2017 (1)
Publications
  1. OncoTargets and Therapy (1)
Publishers
  1. Dove Medical Press Ltd (1)

Results (1)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers
    Journal Article

    Sabari, J. K.; Santini, F. C.; Schram, A. M.; Bergagnini, I.; Chen, R.; Mrad, C.; Lai, W. V.; Arbour, K. C.; Drilon, A.
    OncoTargets and Therapy (2017)

    Fulltext@MSK | Save
  • Follow Us on
    Memorial Sloan Kettering Cancer Center | Memorial Hospital for Cancer and Allied Diseases | Sloan Kettering Institute
    Gerstner Sloan Kettering Graduate School of Biomedical Sciences Patients & Caregivers

    Legal Disclaimer | Giving to the Library
    © 2025 Memorial Sloan Kettering Cancer Center Library